Search Results - "Kutok, J"

Refine Results
  1. 1

    The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL by Balakrishnan, K, Peluso, M, Fu, M, Rosin, N Y, Burger, J A, Wierda, W G, Keating, M J, Faia, K, O'Brien, S, Kutok, J L, Gandhi, V

    Published in Leukemia (01-09-2015)
    “…The functional relevance of the B-cell receptor (BCR) and the evolution of protein kinases as therapeutic targets have recently shifted the paradigm for…”
    Get full text
    Journal Article
  2. 2

    Spectrum of Epstein-Barr virus-associated diseases by Kutok, J L, Wang, F

    Published in Annual review of pathology (01-01-2006)
    “…The association between Epstein-Barr virus (EBV) and a large number of benign and malignant diseases is unique among DNA viruses. Within infected tissues,…”
    Get full text
    Journal Article
  3. 3

    BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells by French, C A, Ramirez, C L, Kolmakova, J, Hickman, T T, Cameron, M J, Thyne, M E, Kutok, J L, Toretsky, J A, Tadavarthy, A K, Kees, U R, Fletcher, J A, Aster, J C

    Published in Oncogene (03-04-2008)
    “…An unusual group of carcinomas, here termed nuclear protein in testis (NUT) midline carcinomas (NMC), are characterized by translocations that involve NUT , a…”
    Get full text
    Journal Article
  4. 4

    Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia by Krajinovic, M, Elbared, J, Drouin, S, Bertout, L, Rezgui, A, Ansari, M, Raboisson, M-J, Lipshultz, S E, Silverman, L B, Sallan, S E, Neuberg, D S, Kutok, J L, Laverdière, C, Sinnett, D, Andelfinger, G

    Published in The pharmacogenomics journal (01-11-2016)
    “…Anthracyclines are efficient chemotherapy agents. However, their use is limited by anthracycline-induced cardiotoxicity (CT). We investigated the influence of…”
    Get full text
    Journal Article
  5. 5

    Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199) by Patel, V M, Balakrishnan, K, Douglas, M, Tibbitts, T, Xu, E Y, Kutok, J L, Ayers, M, Sarkar, A, Guerrieri, R, Wierda, W G, O'Brien, S, Jain, N, Stern, H M, Gandhi, V

    Published in Leukemia (01-09-2017)
    “…Duvelisib, an oral dual inhibitor of PI3K-δ and PI3K-γ, is in phase III trials for the treatment of chronic lymphocytic leukemia (CLL) and indolent…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling by Tournilhac, O., Santos, D. D., Xu, L., Kutok, J., Tai, Y.-T., Le Gouill, S., Catley, L., Hunter, Z., Branagan, A. R., Boyce, J. A., Munshi, N., Anderson, K. C., Treon, S. P.

    Published in Annals of oncology (01-08-2006)
    “…Bone marrow (BM) mast cells (MC) are commonly found in association with lymphoplasmacytic cells (LPC) in patients with Waldenström's macroglobulinemia (WM)…”
    Get full text
    Journal Article
  9. 9
  10. 10

    B cell receptor signal strength determines B cell fate by Casola, Stefano, Rajewsky, Klaus, Otipoby, Kevin L, Alimzhanov, Marat, Humme, Sibille, Uyttersprot, Nathalie, Kutok, Jeffery L, Carroll, Michael C

    Published in Nature immunology (01-03-2004)
    “…B cell receptor (BCR)-mediated antigen recognition is thought to regulate B cell differentiation. BCR signal strength may also influence B cell fate decisions…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation by Frantsve, Julie, Schwaller, Juerg, Sternberg, David W., Kutok, Jeffery, Gilliland, D. Gary

    Published in Molecular and Cellular Biology (01-05-2001)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14

    Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation by Araki, Toshiyuki, Mohi, M Golam, Ismat, Fraz A, Bronson, Roderick T, Williams, Ifor R, Kutok, Jeffery L, Yang, Wentian, Pao, Lily I, Gilliland, D Gary, Epstein, Jonathan A, Neel, Benjamin G

    Published in Nature medicine (01-08-2004)
    “…Noonan syndrome is a common human autosomal dominant birth defect, characterized by short stature, facial abnormalities, heart defects and possibly increased…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Myc-Induced T Cell Leukemia in Transgenic Zebrafish by Langenau, David M., Traver, David, Ferrando, Adolfo A., Kutok, Jeffery L., Aster, Jon C., Kanki, John P., Lin, Shuo, Prochownik, Ed, Trede, Nikolaus S., Zon, Leonard I., Look, A. Thomas

    “…The zebrafish is an attractive model organism for studying cancer development because of its genetic accessibility. Here we describe the induction of clonally…”
    Get full text
    Journal Article
  17. 17

    In vivo Tracking of T Cell Development, Ablation, and Engraftment in Transgenic Zebrafish by Langenau, David M., Ferrando, Adolfo A., Traver, David, Kutok, Jeffery L., Hezel, John-Paul D., Kanki, John P., Zon, Leonard I., Look, A. Thomas, Trede, Nikolaus S., Alt, Frederick W.

    “…Transgenic zebrafish that express GFP under control of the T cell-specific tyrosine kinase (lck) promoter were used to analyze critical aspects of the immune…”
    Get full text
    Journal Article
  18. 18

    53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination by Manis, John P, Morales, Julio C, Xia, Zhenfang, Kutok, Jeffery L, Alt, Frederick W, Carpenter, Phillip B

    Published in Nature immunology (01-05-2004)
    “…The mammalian protein 53BP1 is activated in many cell types in response to genotoxic stress, including DNA double-strand breaks (DSBs). We now examine…”
    Get full text
    Journal Article
  19. 19

    Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 ( PTPN11) mutations by Mohi, M. Golam, Williams, Ifor R., Dearolf, Charles R., Chan, Gordon, Kutok, Jeffery L., Cohen, Sarah, Morgan, Kelly, Boulton, Christina, Shigematsu, Hirokazu, Keilhack, Heike, Akashi, Koichi, Gilliland, D. Gary, Neel, Benjamin G.

    Published in Cancer cell (01-02-2005)
    “…The SH2-containing tyrosine phosphatase Shp2 ( PTPN11) is required for growth factor and cytokine signaling. Germline Shp2 mutations cause Noonan Syndrome…”
    Get full text
    Journal Article
  20. 20

    Bad-Deficient Mice Develop Diffuse Large B Cell Lymphoma by Ranger, Ann M., Zha, Jiping, Harada, Hisashi, Datta, Sandeep Robert, Danial, Nika N., Gilmore, Andrew P., Kutok, Jeffery L., Le Beau, Michelle M., Greenberg, Michael E., Korsmeyer, Stanley J.

    “…The proapoptotic activity of the "BH3-only" molecule BAD can be differentially regulated by survival factor signaling. Bad-deficient mice lacking both BAD long…”
    Get full text
    Journal Article